Hui Zhi Selected Research

Hui Zhi Research Topics

Disease

24	Neoplasms (Cancer) 01/2022 - 03/2012
4	Fibrosis (Cirrhosis) 01/2022 - 08/2011
3	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2014
3	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2007
3	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 10/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 07/2011
3	Type 2 Diabetes Mellitus (MODY) 11/2014 - 11/2012
3	Hypogonadism (Hypergonadotropic Hypogonadism) 05/2012 - 03/2008
2	Pathologic Processes 12/2021 - 01/2015
2	Cognitive Dysfunction 01/2021 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 08/2013
2	Hypertension (High Blood Pressure) 04/2019 - 08/2011
2	Lyme Disease (Disease, Lyme) 01/2019 - 04/2015
2	Carcinoma (Carcinomatosis) 01/2018 - 02/2007
2	Constipation 08/2013 - 06/2011
2	Hypoxia (Hypoxemia) 07/2013 - 07/2011
2	Inflammation (Inflammations) 08/2011 - 07/2011
1	Communicable Diseases (Infectious Diseases) 12/2022
1	Autism Spectrum Disorder 03/2022
1	Adenocarcinoma of Lung 01/2022
1	Hydronephrosis 01/2022
1	Non-alcoholic Fatty Liver Disease 11/2021
1	COVID-19 09/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Fatigue 01/2021
1	Alopecia (Baldness) 01/2021
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2021
1	Hyperpigmentation 01/2021
1	Thyroid Diseases (Thyroid Disease) 02/2019
1	Atherosclerosis 11/2018
1	Infections 01/2018
1	Carcinogenesis 07/2016
1	Autistic Disorder (Autism) 01/2016
1	Angelman Syndrome (Syndrome, Angelman) 01/2016

Drug/Important Bio-Agent (IBA)

15	Long Noncoding RNAIBA 01/2022 - 07/2014
8	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2012
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
6	Competitive Endogenous RNAIBA 01/2022 - 07/2016
4	Messenger RNA (mRNA)IBA 01/2022 - 02/2007
4	Biological ProductsIBA 01/2021 - 01/2015
4	Pharmaceutical PreparationsIBA 01/2019 - 03/2012
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2016
3	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2014
3	Complement System Proteins (Complement)IBA 01/2020 - 01/2018
3	rGLP-1 proteinIBA 11/2014 - 11/2012
3	Testosterone (Sustanon)FDA Link 05/2012 - 03/2008
2	Circular RNAIBA 01/2021 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 10/2016
2	Persistent Organic PollutantsIBA 01/2019 - 11/2018
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2015
2	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2014 - 11/2012
2	Angiotensin IIIBA 08/2011 - 07/2011
2	Dutasteride (Avodart)FDA Link 02/2011 - 03/2008
1	Nucleic AcidsIBA 12/2022
1	Extracellular Matrix ProteinsIBA 01/2022
1	Calcibiotic Root Canal SealerIBA 01/2022
1	ChromatinIBA 01/2022
1	isopentenyl methylenediphosphonateIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	EnzymesIBA 01/2022
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2022
1	Cathepsin BIBA 11/2021
1	InflammasomesIBA 11/2021
1	NLR ProteinsIBA 11/2021
1	Methionine (L-Methionine)FDA Link 11/2021
1	Choline (Choline Chloride)IBA 11/2021
1	carfilzomibIBA 09/2021
1	ixazomibIBA 09/2021
1	Citric Acid (Citrate)FDA LinkGeneric 09/2021
1	Antiviral Agents (Antivirals)IBA 09/2021
1	Bortezomib (Velcade)FDA Link 09/2021
1	Proteasome InhibitorsIBA 09/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	AnthracyclinesIBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	Taxoids (Taxanes)IBA 01/2021
1	CytokinesIBA 01/2021
1	DiterpenesIBA 01/2021
1	AntigensIBA 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2019
1	erucylphosphocholineIBA 04/2019
1	NAD (NADH)IBA 04/2019
1	AutoantibodiesIBA 02/2019
1	decabromobiphenyl ether (decabromodiphenyl ether)IBA 11/2018
1	oxidized low density lipoproteinIBA 11/2018
1	Tamoxifen FDA LinkGeneric 01/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Trastuzumab (Herceptin)FDA Link 05/2016
1	Contrast MediaIBA 05/2016
1	Phospholipids (Phosphatides)FDA LinkGeneric 05/2016
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2016

Therapy/Procedure

6	Therapeutics 01/2022 - 03/2008
4	Drug Therapy (Chemotherapy) 01/2022 - 09/2014
2	Immunotherapy 01/2022 - 01/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2022
1	Acupuncture Therapy 01/2021
1	Acupuncture Points (Acupuncture Point) 01/2021